✦ LIBER ✦

The clinical efficacy of tolterodine extended-release is maintained for 24 h in patients with overactive bladder

✍ Scribed by Roger Dmochowski; Karl Kreder; Scott MacDiarmid; Martin Carlsson; Zhonghong Guan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Symptom-specific efficacy of tolterodine

✍ V. ELINOFF; T. BAVENDAM; D. B. GLASSER; M. CARLSSON; N. EYLAND; R. ROBERTS 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

Efficacy and tolerability of tolterodine

✍ VICTOR W. NITTI; ROGER DMOCHOWSKI; RODNEY A. APPELL; JOSEPH T. WANG; TAMARA BAVE 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

Long-term safety, tolerability and effic

✍ MINEO TAKEI; YUKIO HOMMA; THE JAPANESE TOLTERODINE STUDY GROUP 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

Clinical Efficacy and Safety of Tolterod

✍ H. P. Drutz; R. A. Appell; D. Gleason; I. Klimberg; S. Radomski 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 108 KB

Effectiveness and tolerability of extend

✍ Rodney U. Anderson; Scott MacDiarmid; Sherron Kell; James H. Barada; Scott Serel 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 137 KB

The cost-effectiveness of solifenacin vs

✍ Linda Cardozo; Andrew Thorpe; Juliet Warner; Manpreet Sidhu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB